So, one theory we should consider is that the impairments were introduced for the specific purpose of offsetting capital gains created by a DBCT sale. I have not done my homework to know if such an impairment was needed for that effect. Perhaps they have sufficient carry forward losses to already offset such a gain.
If that theory is correct, it would suggest they anticipate a gain on the DBCT sale (which would be bullish).
BBI Price at posting:
6.8¢ Sentiment: LT Buy Disclosure: Not Held
